Follow up visits were scheduled one month, 3 months and six months from the first injection. Before and after injection, each patient was asked to complete Tinnitus Handicap Inventory (THI) and Tinnitus Functional Index (TFI) questionnaires. Full otological, audiological examination and adverse events were recorded.